US Stock MarketDetailed Quotes

LGND Ligand Pharmaceuticals

Watchlist
  • 121.470
  • -1.080-0.88%
Close Nov 29 13:00 ET
  • 121.470
  • 0.0000.00%
Post 17:01 ET
2.30BMarket Cap48.78P/E (TTM)

Ligand Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
57.64%51.81M
57.52%41.53M
-29.56%30.98M
-33.09%131.31M
-44.22%28.1M
-44.50%32.87M
-47.40%26.37M
20.44%43.98M
-18.75%196.25M
36.60%50.38M
Operating revenue
57.64%51.81M
57.52%41.53M
-29.56%30.98M
-33.09%131.31M
-44.22%28.1M
-44.50%32.87M
-47.40%26.37M
20.44%43.98M
-18.75%196.25M
36.60%50.38M
Cost of revenue
-29.73%2.45M
74.12%2.91M
-22.46%2.88M
-80.10%10.51M
-92.41%1.64M
-75.38%3.49M
-86.50%1.67M
-20.90%3.72M
-15.04%52.83M
80.36%21.61M
Gross profit
68.00%49.36M
56.40%38.63M
-30.22%28.1M
-15.77%120.8M
-8.02%26.46M
-34.80%29.38M
-34.60%24.7M
26.54%40.26M
-20.04%143.42M
15.53%28.77M
Operating expense
35.12%38.41M
17.07%31.23M
-3.64%25.11M
-20.94%110.98M
-38.98%29.82M
-13.14%28.43M
-8.33%26.68M
-12.22%26.06M
85.89%140.38M
482.07%48.87M
Selling and administrative expenses
67.00%24.48M
56.14%17.62M
0.88%10.95M
-24.65%52.79M
-48.63%15.99M
-1.77%14.66M
-6.61%11.29M
-8.97%10.86M
49.74%70.06M
342.01%31.13M
-General and administrative expense
67.00%24.48M
56.14%17.62M
0.88%10.95M
-24.65%52.79M
-48.63%15.99M
-1.77%14.66M
-6.61%11.29M
-8.97%10.86M
49.74%70.06M
342.01%31.13M
Research and development costs
2.58%5.68M
-21.89%5.35M
-10.39%5.97M
-32.00%24.54M
-40.33%5.49M
-40.12%5.53M
-19.05%6.85M
-27.41%6.66M
12.39%36.08M
149.28%9.2M
Depreciation amortization depletion
0.24%8.26M
-3.30%8.26M
-4.13%8.19M
-1.70%33.65M
-2.35%8.34M
-3.85%8.24M
-0.13%8.54M
-0.48%8.54M
0.04%34.24M
830.45%8.54M
-Depreciation and amortization
0.24%8.26M
-3.30%8.26M
-4.13%8.19M
-1.70%33.65M
-2.35%8.34M
-3.85%8.24M
-0.13%8.54M
-0.48%8.54M
0.04%34.24M
830.45%8.54M
Operating profit
1,044.72%10.96M
472.72%7.39M
-78.97%2.99M
223.38%9.82M
83.29%-3.36M
-92.25%957K
-122.89%-1.98M
565.96%14.21M
-97.08%3.04M
-153.33%-20.1M
Net non-operating interest income expense
-73.21%606K
-26.87%1.49M
57.24%1.88M
2,756.28%7.06M
99.49%1.56M
773.36%2.26M
1,554.29%2.04M
282.44%1.2M
101.32%247K
118.31%783K
Non-operating interest income
-40.48%1.35M
18.84%2.76M
40.77%2.02M
276.88%7.71M
65.49%1.69M
282.91%2.26M
678.52%2.32M
970.90%1.44M
130.93%2.05M
444.15%1.02M
Non-operating interest expense
74,000.00%741K
346.48%1.27M
-41.25%141K
-63.54%656K
-45.42%131K
-99.70%1K
-35.16%284K
-69.58%240K
-90.83%1.8M
-94.62%240K
Other net income (expense)
-16.51%-17.9M
-2,481.98%-74.27M
170.53%108.58M
42.95%46.78M
-56.52%18.89M
-6,145.12%-15.36M
2,143.17%3.12M
477.86%40.14M
353.44%32.73M
379.78%43.46M
Gain on sale of security
59.00%-5.41M
-457.20%-14.26M
180.70%110.97M
63.33%46.62M
-63.22%16.28M
-1,328.39%-13.18M
309.06%3.99M
407.00%39.53M
642.28%28.54M
430.27%44.25M
Special income (charges)
--0
---26.49M
----
--2.12M
--0
--2.12M
--0
----
--0
--0
-Less:Impairment of capital assets
--0
--26.49M
----
----
----
--0
--0
----
----
----
-Gain on sale of business
--0
----
----
----
----
--2.12M
----
----
----
----
-Gain on sale of property,plant,equipment
----
----
----
--2.12M
----
----
----
----
--0
--0
Other non- operating income (expenses)
-190.58%-12.5M
-3,739.98%-33.52M
-496.02%-2.39M
-146.62%-1.95M
430.14%2.62M
-735.16%-4.3M
-142.63%-873K
-73.26%603K
154.73%4.19M
62.84%-793K
Income before tax
47.80%-6.34M
-2,162.13%-65.39M
104.28%113.45M
76.78%63.66M
-29.18%17.1M
-198.30%-12.14M
-63.39%3.17M
707.35%55.54M
-50.13%36.01M
35.00%24.14M
Income tax
144.52%833K
-1,629.97%-13.48M
129.06%27.31M
-76.13%9.84M
-102.82%-1.09M
-169.07%-1.87M
122.37%881K
214.98%11.92M
1,093.97%41.23M
847.43%38.67M
Net income
30.19%-7.17M
-2,366.86%-51.91M
105.34%86.14M
256.33%52.15M
204.02%18.19M
-2,642.82%-10.27M
355.87%2.29M
372.66%41.95M
-158.39%-33.36M
-222.84%-17.49M
Net income continuous Operations
30.19%-7.17M
-2,366.86%-51.91M
97.50%86.14M
1,131.21%53.82M
225.14%18.19M
-206.51%-10.27M
-81.82%2.29M
437.33%43.61M
-106.84%-5.22M
-205.33%-14.53M
Net income discontinuous operations
--0
--0
--0
94.08%-1.67M
--0
--0
--0
32.21%-1.67M
-46.46%-28.14M
---2.95M
Minority interest income
Net income attributable to the parent company
30.19%-7.17M
-2,366.86%-51.91M
105.34%86.14M
256.33%52.15M
204.02%18.19M
-2,642.82%-10.27M
355.87%2.29M
372.66%41.95M
-158.39%-33.36M
-222.84%-17.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.19%-7.17M
-2,366.86%-51.91M
105.34%86.14M
256.33%52.15M
204.02%18.19M
-2,642.82%-10.27M
355.87%2.29M
372.66%41.95M
-158.39%-33.36M
-222.84%-17.49M
Basic earnings per share
33.90%-0.39
-2,315.38%-2.88
97.56%4.86
252.53%3.02
200.00%1.04
-3,050.00%-0.59
360.00%0.13
370.33%2.46
-157.56%-1.98
-246.67%-1.04
Diluted earnings per share
33.90%-0.39
-2,315.38%-2.88
103.86%4.75
248.48%2.94
199.04%1.03
-3,050.00%-0.59
360.00%0.13
356.04%2.33
-159.82%-1.98
-246.67%-1.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 57.64%51.81M57.52%41.53M-29.56%30.98M-33.09%131.31M-44.22%28.1M-44.50%32.87M-47.40%26.37M20.44%43.98M-18.75%196.25M36.60%50.38M
Operating revenue 57.64%51.81M57.52%41.53M-29.56%30.98M-33.09%131.31M-44.22%28.1M-44.50%32.87M-47.40%26.37M20.44%43.98M-18.75%196.25M36.60%50.38M
Cost of revenue -29.73%2.45M74.12%2.91M-22.46%2.88M-80.10%10.51M-92.41%1.64M-75.38%3.49M-86.50%1.67M-20.90%3.72M-15.04%52.83M80.36%21.61M
Gross profit 68.00%49.36M56.40%38.63M-30.22%28.1M-15.77%120.8M-8.02%26.46M-34.80%29.38M-34.60%24.7M26.54%40.26M-20.04%143.42M15.53%28.77M
Operating expense 35.12%38.41M17.07%31.23M-3.64%25.11M-20.94%110.98M-38.98%29.82M-13.14%28.43M-8.33%26.68M-12.22%26.06M85.89%140.38M482.07%48.87M
Selling and administrative expenses 67.00%24.48M56.14%17.62M0.88%10.95M-24.65%52.79M-48.63%15.99M-1.77%14.66M-6.61%11.29M-8.97%10.86M49.74%70.06M342.01%31.13M
-General and administrative expense 67.00%24.48M56.14%17.62M0.88%10.95M-24.65%52.79M-48.63%15.99M-1.77%14.66M-6.61%11.29M-8.97%10.86M49.74%70.06M342.01%31.13M
Research and development costs 2.58%5.68M-21.89%5.35M-10.39%5.97M-32.00%24.54M-40.33%5.49M-40.12%5.53M-19.05%6.85M-27.41%6.66M12.39%36.08M149.28%9.2M
Depreciation amortization depletion 0.24%8.26M-3.30%8.26M-4.13%8.19M-1.70%33.65M-2.35%8.34M-3.85%8.24M-0.13%8.54M-0.48%8.54M0.04%34.24M830.45%8.54M
-Depreciation and amortization 0.24%8.26M-3.30%8.26M-4.13%8.19M-1.70%33.65M-2.35%8.34M-3.85%8.24M-0.13%8.54M-0.48%8.54M0.04%34.24M830.45%8.54M
Operating profit 1,044.72%10.96M472.72%7.39M-78.97%2.99M223.38%9.82M83.29%-3.36M-92.25%957K-122.89%-1.98M565.96%14.21M-97.08%3.04M-153.33%-20.1M
Net non-operating interest income expense -73.21%606K-26.87%1.49M57.24%1.88M2,756.28%7.06M99.49%1.56M773.36%2.26M1,554.29%2.04M282.44%1.2M101.32%247K118.31%783K
Non-operating interest income -40.48%1.35M18.84%2.76M40.77%2.02M276.88%7.71M65.49%1.69M282.91%2.26M678.52%2.32M970.90%1.44M130.93%2.05M444.15%1.02M
Non-operating interest expense 74,000.00%741K346.48%1.27M-41.25%141K-63.54%656K-45.42%131K-99.70%1K-35.16%284K-69.58%240K-90.83%1.8M-94.62%240K
Other net income (expense) -16.51%-17.9M-2,481.98%-74.27M170.53%108.58M42.95%46.78M-56.52%18.89M-6,145.12%-15.36M2,143.17%3.12M477.86%40.14M353.44%32.73M379.78%43.46M
Gain on sale of security 59.00%-5.41M-457.20%-14.26M180.70%110.97M63.33%46.62M-63.22%16.28M-1,328.39%-13.18M309.06%3.99M407.00%39.53M642.28%28.54M430.27%44.25M
Special income (charges) --0---26.49M------2.12M--0--2.12M--0------0--0
-Less:Impairment of capital assets --0--26.49M--------------0--0------------
-Gain on sale of business --0------------------2.12M----------------
-Gain on sale of property,plant,equipment --------------2.12M------------------0--0
Other non- operating income (expenses) -190.58%-12.5M-3,739.98%-33.52M-496.02%-2.39M-146.62%-1.95M430.14%2.62M-735.16%-4.3M-142.63%-873K-73.26%603K154.73%4.19M62.84%-793K
Income before tax 47.80%-6.34M-2,162.13%-65.39M104.28%113.45M76.78%63.66M-29.18%17.1M-198.30%-12.14M-63.39%3.17M707.35%55.54M-50.13%36.01M35.00%24.14M
Income tax 144.52%833K-1,629.97%-13.48M129.06%27.31M-76.13%9.84M-102.82%-1.09M-169.07%-1.87M122.37%881K214.98%11.92M1,093.97%41.23M847.43%38.67M
Net income 30.19%-7.17M-2,366.86%-51.91M105.34%86.14M256.33%52.15M204.02%18.19M-2,642.82%-10.27M355.87%2.29M372.66%41.95M-158.39%-33.36M-222.84%-17.49M
Net income continuous Operations 30.19%-7.17M-2,366.86%-51.91M97.50%86.14M1,131.21%53.82M225.14%18.19M-206.51%-10.27M-81.82%2.29M437.33%43.61M-106.84%-5.22M-205.33%-14.53M
Net income discontinuous operations --0--0--094.08%-1.67M--0--0--032.21%-1.67M-46.46%-28.14M---2.95M
Minority interest income
Net income attributable to the parent company 30.19%-7.17M-2,366.86%-51.91M105.34%86.14M256.33%52.15M204.02%18.19M-2,642.82%-10.27M355.87%2.29M372.66%41.95M-158.39%-33.36M-222.84%-17.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.19%-7.17M-2,366.86%-51.91M105.34%86.14M256.33%52.15M204.02%18.19M-2,642.82%-10.27M355.87%2.29M372.66%41.95M-158.39%-33.36M-222.84%-17.49M
Basic earnings per share 33.90%-0.39-2,315.38%-2.8897.56%4.86252.53%3.02200.00%1.04-3,050.00%-0.59360.00%0.13370.33%2.46-157.56%-1.98-246.67%-1.04
Diluted earnings per share 33.90%-0.39-2,315.38%-2.88103.86%4.75248.48%2.94199.04%1.03-3,050.00%-0.59360.00%0.13356.04%2.33-159.82%-1.98-246.67%-1.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data